Tilak Healthcare
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tilak Healthcare - overview
Established
2016
Location
Paris, -, France
Primary Industry
Software
About
Tilak Healthcare is a French company focused on the development of innovative digital solutions for monitoring chronic eye diseases, leveraging mobile technology to improve patient engagement and care. Founded in 2016 and headquartered in Paris, France, Tilak Healthcare is dedicated to developing mobile applications for remote health monitoring. The company's founders, Edouard Gasser and Jean-François GIRMENS, have a background in digital health innovations. The company has successfully completed 3 funding rounds, with the most recent deal occurring on October 12, 2023, where it raised EUR 10 million from various investors including Cap Horn and Elaia Partners.
This funding has brought the total amount raised to EUR 10 million. Tilak Healthcare specializes in OdySight®, a clinically validated mobile medical application designed for the remote monitoring of chronic retinal conditions. This platform integrates medically-approved visual tests with an engaging gaming experience to enhance patient participation. OdySight® is aimed at patients with maculopathies, allowing them to monitor their visual parameters from home while staying connected to their healthcare providers, primarily within the European market since its launch in 2016, particularly addressing the needs of the approximately 2.
2 billion people worldwide affected by visual impairments. In 2023, Tilak Healthcare reported a revenue of EUR 1,345,416. 70. The company operates a transactional model based on prescriptions from healthcare providers, generating revenue through B2B partnerships that facilitate patient subscriptions to OdySight®.
This revenue structure focuses on maintaining relationships with healthcare professionals to ensure compliance and quality standards. Following the recent funding round in October 2023, Tilak Healthcare plans to accelerate the roll-out of OdySight both in France and internationally. The funding will also support the development of new solutions for other medical conditions, expanding the company's reach and enhancing its product offerings.
Current Investors
iBionext, Elaia Partners, SWEN Capital Partners
Primary Industry
Software
Sub Industries
Healthcare IT, Medical Devices & Equipment, Gaming
Website
www.tilakhealthcare.com
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.